Another interesting note from the California Stem Cell Report: David Jensen links to an article in the Milwaukee Journal which notes that Wisconsin stands to collect if California’s $3 billion investment pays off:
The Wisconsin Alumni Research Foundation, or WARF, has two basic patents that broadly cover the preparation of embryonic stem cells, the basic material from which virtually all organs, cells and other body tissues are formed.
If therapies are developed from the research, WARF could be due royalty payments.
“You can allocate $3 billion for research, but you can’t spend your way past the basic patents that are in the field,” said Peter Balbus, managing director at Pragmaxis LLC. The Glen Ellyn, Ill., company helps commercialize technology. “I think WARF is really in the catbird’s seat.”
The $200 million estimate is based on the claims of Prop 71 supporters that stem cell technologies would generate $4 billion a year in revenues.
Did this come up before the vote?